Australia's most trusted
source of pharma news
Friday, 18 October 2024
Posted 22 November 2022 AM
Attempts to resuscitate the supply of urgently needed diabetes medications has hit a brick wall over the price of emergency supplies of imported products.
Public Summary Documents reveal that despite two out-of-session PBAC meetings, a standoff has emerged between the Committee and Medsurge Healthcare, supplier of the imported product.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.